Loading Events

« All Events

Mitochondria-Targeted Drug Development Summit

22 February, 2022 - 24 February, 2022

Abliva will attend and present at the Mitochondria-Targeted Drug Development Summit in Boston, MA, USA. The event will be held on 22 – 24 February 2022.

CEO Ellen Donnelly will be presenting in the session Patient-Focused Drug Development for Mitochondrial Disease.

Synopsis:

  • Highlighting the impact of patient input on research and development at Abliva
  • Providing an overview of the multiple therapeutic options for mitochondrial disease being pursued at Abliva
  • Presenting placebo controlled PMD patient data from our lead asset, KL1333

Details

Start:
22 February, 2022
End:
24 February, 2022
Event Category:
Website:
https://mitochondria-targets.com

Organizer

Hanson Wade

Venue

Hyatt Regency Boston/Cambridge
575 Memorial Dr
Cambridge, Massachusetts 02139 United States
+ Google Map
Website:
https://www.hyatt.com/en-US/hotel/massachusetts/hyatt-regency-boston-cambridge/bosrc